144 related articles for article (PubMed ID: 22983734)
1. Criteria for the glucagon provocative test in the diagnosis of gastrinoma.
Shibata C; Kakyo M; Kinouchi M; Tanaka N; Miura K; Naitoh T; Ogawa H; Motoi F; Egawa S; Ueno T; Naito H; Unno M
Surg Today; 2013 Nov; 43(11):1281-5. PubMed ID: 22983734
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of selective arterial calcium injection test for localization of gastrinoma.
Hayashi R; Minami I; Sasahara Y; Izumiyama H; Yoshimoto T; Kishino M; Kudo A; Tateishi U; Tanabe M; Yamada T
Endocr J; 2020 Mar; 67(3):305-315. PubMed ID: 31813923
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasm, type 1. Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases.
Shepherd JJ; Challis DR; Davies PF; McArdle JP; Teh BT; Wilkinson S
Arch Surg; 1993 Oct; 128(10):1133-42. PubMed ID: 8105768
[TBL] [Abstract][Full Text] [Related]
5. The glucagon provocative test for the diagnosis and treatment of Zollinger-Ellison syndrome.
Shibata C; Funayama Y; Fukushima K; Ueno T; Kohyama A; Satoh K; Shimosegawa T; Yamagiwa T; Sasaki I
J Gastrointest Surg; 2008 Feb; 12(2):344-9. PubMed ID: 17929104
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.
Syversen U; Mignon M; Bonfils S; Kristensen A; Waldum HL
Acta Oncol; 1993; 32(2):161-5. PubMed ID: 8323758
[TBL] [Abstract][Full Text] [Related]
7. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists.
Dhillo WS; Jayasena CN; Lewis CJ; Martin NM; Tang KC; Meeran K; Todd JF
Ann Clin Biochem; 2006 Mar; 43(Pt 2):153-5. PubMed ID: 16536918
[TBL] [Abstract][Full Text] [Related]
8. Processing-independent analysis in the diagnosis of gastrinomas.
Jørgensen NR; Rehfeld JF; Bardram L; Hilsted L
Scand J Gastroenterol; 1998 Apr; 33(4):379-85. PubMed ID: 9605259
[TBL] [Abstract][Full Text] [Related]
9. Gastrinoma: a retrospective study of four cases (1985-1995).
Green RA; Gartrell CL
J Am Anim Hosp Assoc; 1997; 33(6):524-7. PubMed ID: 9358421
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of chromogranin A versus gastrin and progastrin in gastrinoma diagnosis and control.
Rehfeld JF; Bardram L; Hilsted L; Goetze JP
Biomark Med; 2014; 8(4):571-80. PubMed ID: 24796622
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
Banasch M; Schmitz F
Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four provocative tests for the diagnosis of gastrinoma.
Romanus ME; Neal JA; Dilley WG; Leight GS; Linehan WM; Santen RJ; Farndon JR; Jones RS; Wells SA
Ann Surg; 1983 May; 197(5):608-17. PubMed ID: 6847280
[TBL] [Abstract][Full Text] [Related]
13. Primary extrapancreatic gastrinoma.
Pai PR; Shahani RB; Shah HK; Dalvi AN; Samsi AB; Vora IM
J Postgrad Med; 1992; 38(4):210-1, 207. PubMed ID: 1307600
[TBL] [Abstract][Full Text] [Related]
14. Source of plasma chromogranin A elevation in gastrinoma patients.
Stabile BE; Howard TJ; Passaro E; O'Connor DT
Arch Surg; 1990 Apr; 125(4):451-3. PubMed ID: 2322109
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of sporadic gastrinoma.
Lorenz K; Dralle H
Wien Klin Wochenschr; 2007; 119(19-20):597-601. PubMed ID: 17985095
[TBL] [Abstract][Full Text] [Related]
16. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
Woltering EA; Mozell EJ; O'Dorisio TM; Fletcher WS; Howe B
Surg Gynecol Obstet; 1988 Dec; 167(6):453-62. PubMed ID: 2460958
[TBL] [Abstract][Full Text] [Related]
17. Use of calcium provocative test in the diagnosis of gastroenteropancreatic endocrine tumors.
Vezzadini C; Poggioli R; Casoni I; Vezzadini P
Panminerva Med; 1996 Dec; 38(4):255-8. PubMed ID: 9063035
[TBL] [Abstract][Full Text] [Related]
18. Normal serum gastrin concentration in gastrinoma.
Jaïs P; Mignon M
Lancet; 1995 Nov; 346(8987):1421-2. PubMed ID: 7475830
[No Abstract] [Full Text] [Related]
19. Hypergastrinemia--diagnosis and treatment.
Niederle B
Wien Klin Wochenschr; 2007; 119(19-20):561-3. PubMed ID: 17985087
[No Abstract] [Full Text] [Related]
20. Selective arterial stimulation of secretin in localization of gastrinomas.
Rosato FE; Bonn J; Shapiro M; BarBot DJ; Furnary AM; Gardiner GA
Surg Gynecol Obstet; 1990 Sep; 171(3):196-200. PubMed ID: 2166970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
